GLOBAL FAIR MARKET VALUE
FMV Data & HCP Tiering Solutions
for Life Sciences
Structured FMV data grounded in a published methodology
for pharmaceutical, biotech and medical device companies
Work with FMV Specialists Focused on Life Sciences
Fairmark provides global Fair Market Value (FMV) data, HCP tiering, and rate-setting solutions for pharmaceutical, biotech, and medical device organizations, designed for HCP engagements and clinical research. Our work focuses on HCP speaking, consulting, and advisory services, where defensible rate setting and consistent tiering are critical for compliance. Our structured, objective methodology enables consistent fair market value determination across these use cases.
Our Solutions
FairTier™ provides a structured framework for determining an HCP’s FMV tier based on objective measures of expertise documented in the CV. The framework supports clear, well-documented tiering decisions and has been applied across major global markets.
FairClin™ provides a hybrid valuation approach to clinical trial FMV grounded in the same methodology used for HCP engagement rate setting. This supports consistent, defensible compensation across clinical research activities, aligned with protocol complexity and operational requirements.
FairRate™, is a comprehensive FMV database covering over 200 physician and allied HCP specialties across major global markets (United States, Europe, Asia Pacific, the Americas, and the Middle East & Africa).
Structured rate ranges and fee schedules support compensation decisions across a broad range of HCP speaking and consulting activities. The FairRate™ Calculator enables activity-based fee determinations, supporting practical application of FMV in real-world engagement scenarios.